These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 21890376)

  • 21. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation.
    Ma TY; Iwamoto GK; Hoa NT; Akotia V; Pedram A; Boivin MA; Said HM
    Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G367-76. PubMed ID: 14766535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms.
    Schwarz BT; Wang F; Shen L; Clayburgh DR; Su L; Wang Y; Fu YX; Turner JR
    Gastroenterology; 2007 Jun; 132(7):2383-94. PubMed ID: 17570213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure.
    Shen L; Black ED; Witkowski ED; Lencer WI; Guerriero V; Schneeberger EE; Turner JR
    J Cell Sci; 2006 May; 119(Pt 10):2095-106. PubMed ID: 16638813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression.
    Yeh WL; Lu DY; Lin CJ; Liou HC; Fu WM
    Mol Pharmacol; 2007 Aug; 72(2):440-9. PubMed ID: 17513385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury.
    Jin Y; Blikslager AT
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C996-C1004. PubMed ID: 27760753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease.
    Zolotarevsky Y; Hecht G; Koutsouris A; Gonzalez DE; Quan C; Tom J; Mrsny RJ; Turner JR
    Gastroenterology; 2002 Jul; 123(1):163-72. PubMed ID: 12105845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions.
    Qasim M; Rahman H; Ahmed R; Oellerich M; Asif AR
    Exp Cell Res; 2014 Apr; 322(2):277-89. PubMed ID: 24509232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AGR2 ameliorates tumor necrosis factor-α-induced epithelial barrier dysfunction via suppression of NF-κB p65-mediated MLCK/p-MLC pathway activation.
    Ye X; Sun M
    Int J Mol Med; 2017 May; 39(5):1206-1214. PubMed ID: 28339048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Numb modulates the paracellular permeability of intestinal epithelial cells through regulating apical junctional complex assembly and myosin light chain phosphorylation.
    Yang Y; Chen L; Tian Y; Ye J; Liu Y; Song L; Pan Q; He Y; Chen W; Peng Z; Wang R
    Exp Cell Res; 2013 Dec; 319(20):3214-25. PubMed ID: 23872314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1,25-Dihydroxyvitamin D3 preserves intestinal epithelial barrier function from TNF-α induced injury via suppression of NF-kB p65 mediated MLCK-P-MLC signaling pathway.
    Chen S; Zhu J; Chen G; Zuo S; Zhang J; Chen Z; Wang X; Li J; Liu Y; Wang P
    Biochem Biophys Res Commun; 2015 May; 460(3):873-8. PubMed ID: 25838204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
    Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
    Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. n-3 polyunsaturated fatty acids prevent disruption of epithelial barrier function induced by proinflammatory cytokines.
    Li Q; Zhang Q; Wang M; Zhao S; Xu G; Li J
    Mol Immunol; 2008 Mar; 45(5):1356-65. PubMed ID: 17936906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aryl Hydrocarbon Receptor Activation Modulates Intestinal Epithelial Barrier Function by Maintaining Tight Junction Integrity.
    Yu M; Wang Q; Ma Y; Li L; Yu K; Zhang Z; Chen G; Li X; Xiao W; Xu P; Yang H
    Int J Biol Sci; 2018; 14(1):69-77. PubMed ID: 29483826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential regulation of human lung epithelial and endothelial barrier function by thrombin.
    Kawkitinarong K; Linz-McGillem L; Birukov KG; Garcia JG
    Am J Respir Cell Mol Biol; 2004 Nov; 31(5):517-27. PubMed ID: 15284075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell wall fraction of Enterococcus hirae ameliorates TNF-alpha-induced barrier impairment in the human epithelial tight junction.
    Miyauchi E; Morita H; Okuda J; Sashihara T; Shimizu M; Tanabe S
    Lett Appl Microbiol; 2008 Apr; 46(4):469-76. PubMed ID: 18298454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier.
    Boivin MA; Ye D; Kennedy JC; Al-Sadi R; Shepela C; Ma TY
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G590-8. PubMed ID: 17068119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor alpha increases epithelial barrier permeability by disrupting tight junctions in Caco-2 cells.
    Cui W; Li LX; Sun CM; Wen Y; Zhou Y; Dong YL; Liu P
    Braz J Med Biol Res; 2010 Apr; 43(4):330-7. PubMed ID: 20445948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin regulates tight junction of intestinal epithelial cells via MLCK-MLC signaling pathway.
    Zhou HY; Zhu H; Yao XM; Qian JP; Yang J; Pan XD; Chen XD
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5239-5246. PubMed ID: 29228440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-200b inhibits TNF-α-induced IL-8 secretion and tight junction disruption of intestinal epithelial cells in vitro.
    Shen Y; Zhou M; Yan J; Gong Z; Xiao Y; Zhang C; Du P; Chen Y
    Am J Physiol Gastrointest Liver Physiol; 2017 Feb; 312(2):G123-G132. PubMed ID: 27979826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valproic acid treatment inhibits hypoxia-inducible factor 1α accumulation and protects against burn-induced gut barrier dysfunction in a rodent model.
    Luo HM; Du MH; Lin ZL; Zhang L; Ma L; Wang H; Yu W; Lv Y; Lu JY; Pi YL; Hu S; Sheng ZY
    PLoS One; 2013; 8(10):e77523. PubMed ID: 24147016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.